Q1 2022 dividend increases to $0.05 from $0.04 per share in Q1 2021 BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company’s common stock. The dividend will be paid on March 18,... Read more
Collaboration aims to evolve precision medicine with cell-specific delivery of gene therapy WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that its SIRION Biotech business, a world leader in viral vector-based gene delivery technologies for gene and cell therapy and vaccine development, and the Centre for Genomic Regulation (CRG), an international... Read more
Q4 2021 revenues $683.5M, up 8.9% year-over-year (yoy); organic revenue growth of 11.4% yoy Q4 2021 GAAP EPS $0.50; non-GAAP EPS $0.59, up $0.01 yoy FY 2021 revenues of $2.42B, up 21.7% yoy; organic revenue growth of 19.1% yoy FY 2021 GAAP EPS $1.81; non-GAAP EPS $2.10, up 55.6% yoy Solid organic revenue and non-GAAP... Read more
WALTHAM, Mass.–(BUSINESS WIRE)–Feb. 10, 2022– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at Citi’s 2022 Virtual Healthcare Conference on Thursday, February 24, 2022 at 8:45 a.m. ET. Prahlad Singh, president and chief executive officer of PerkinElmer, will provide an overview on... Read more
BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 11th Annual SVB Leerink Global Healthcare Conference, being held virtually. Frank Laukien, Chairman, President & CEO will present on behalf of the Company on Wednesday, February 16th, 2022 at 8:40 AM Eastern Standard Time. A live audio webcast of the presentation... Read more
Thermo Fisher Scientific expands Applied Biosystems portfolio with the latest generation of innovative, mid-throughput genetic analyzers CARLSBAD, Calif.–(BUSINESS WIRE)– Capillary electrophoresis (CE), which enables Sanger sequencing and fragment analysis,is an important tool for improving clinical research and advancing scientific discovery. To further enable customers’ cutting-edge research in areas such as gene editing and infectious disease,... Read more
Sierra Surface Plasmon Resonance (SPR) Pro Series for High-Throughput Screening (HTS) Innovative Sierra SPR-32 Pro allowing multiplex HTS for insights into kinetics with no compromise in sensitivity and nature of samples SPR insights into molecular interactions by label-free HTS in support of drug discovery BOSTON–(BUSINESS WIRE)– At the SLAS2022 International Conference and Exhibition, Bruker Corporation... Read more
timsTOF MALDI PharmaPulse® (timsTOF MPP) for Unprecedented High-Throughput Screening (HTS) information content and throughput Innovative timsTOF platform combined with extreme MALDI PharmaPulse speed and robustness for unbiased, deep HTS and uHTS (ultra-high-throughput screening) Trapped Ion Mobility Spectrometry (TIMS): Exploiting ion mobility separation as a new dimension in HTS combined with high resolution QTOF-MS Enabling new... Read more